Back to Search
Start Over
Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients
- Source :
- Pharmacogenomics; February 2022, Vol. 23 Issue: 3 p161-171, 11p
- Publication Year :
- 2022
-
Abstract
- Aim:To investigate the transcriptional changes induced by Fingolimod (FTY) in T cells of relapsing remitting multiple sclerosis patients. Patients & methods:Transcriptomic changes after 6 months of FTY therapy were evaluated on T cells from 24 relapsing remitting multiple sclerosis patients through RNA-sequencing, followed by technical validation and pathway analysis. Results:Among differentially expressed genes, CX3CR1and CCR7resulted strongly up- and downregulated, respectively. Two relevant genes were validated with quantitative PCR and we largely confirmed findings from two previous microarray-based studies with similar design. Pathway analysis pointed to an involvement of processes related to immune function and cell migration. Conclusion:Our data support the evidence that FTY induces major transcriptional changes in genes involved in immune response and cell trafficking in T lymphocytes.
Details
- Language :
- English
- ISSN :
- 14622416 and 17448042
- Volume :
- 23
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Pharmacogenomics
- Publication Type :
- Periodical
- Accession number :
- ejs58746556
- Full Text :
- https://doi.org/10.2217/pgs-2021-0118